OIS
RPRX icon

OneAscent Investment Solutions’s Royalty Pharma RPRX Stock Holding History

OneAscent Investment Solutions’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$644K Sell
11,478
-1,051
-8% -$54.7K 0.61% 35
2026
Q1 		$601K Sell
12,529
-1,036
-8% -$45.4K 0.6% 35
2025
Q4 		$524K Buy
13,565
+4,813
+55% +$184K 0.56% 37
2025
Q3 		$309K Sell
8,752
-5,556
-39% -$201K 0.33% 92
2025
Q2 		$516K Buy
14,308
+3,013
+27% +$99.8K 0.55% 48
2025
Q1 		$352K Buy
+11,295
New +$358K 0.42% 72

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OneAscent Investment Solutions's RPRX Position: Q2 2026 in Review

OneAscent Investment Solutions reduced its Royalty Pharma (RPRX) stake by 8.4% in Q2 2026, selling an estimated $54.7K and leaving 11,478 shares worth $644K. The position accounts for 0.61% of the portfolio, ranked #35.

OneAscent Investment Solutions first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • OneAscent Investment Solutions held 11,478 shares of Royalty Pharma worth $644K as of Q2 2026.
  • OneAscent Investment Solutions sold 1,051 Royalty Pharma shares in Q2 2026, an estimated $54.7K.
  • Royalty Pharma made up 0.61% of OneAscent Investment Solutions's portfolio in Q2 2026, its #35 holding.
  • OneAscent Investment Solutions first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on OneAscent Investment Solutions's 13F filing for Q2 2026, filed 11 Aug 2026.